SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Completed · Phase 3
Conditions studied: Metastatic Breast Cancer
In brief
The purpose of this study is to demonstrate that SYD985 \[(vic-)trastuzumab duocarmazine\] is superior to physician's choice in prolonging progression free survival.
Key facts
- Study ID
- NCT03262935
- Run by
- Byondis B.V.
- People needed
- 437
- Starts
- 2017-12-15
- Expected to finish
- 2022-06-30
- Last updated by the study team
- 2023-10-19
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Istituto Europeo di Oncologia — Milan, Italy
- University Hospital of Modena — Modena, Italy
- Ospedale San Gerardo-Asst Monza — Monza, Italy
- Istituto Oncologico Veneto Irccs — Padova, Italy
- Nuovo Ospedale Santo Stefano — Prato, Italy
- Istituto Nazionale dei Tumori Regina Elena — Roma, Italy
- Azienda Ospedaliera Sant'Andrea — Roma, Italy
- Casa Sollievo Della Sofferenza — San Giovanni Rotondo, Italy
- Radboud University Medical Center — Nijmegen, Gelderland, Netherlands
- VU Medical Center — Amsterdam, North Holland, Netherlands
- University Medical Center Groningen — Groningen, Netherlands
- National University Cancer Institute — Singapore, Singapore
- National Cancer Centre Singapore — Singapore, Singapore
- Hospital General Universitario de Alicante — Alicante, Spain
- Hospital Quironsalud — Barcelona, Spain
- Hospital Universitari Vall d'Hebron Vall d' Hebron Institute of Oncology (VHIO) — Barcelona, Spain
- Hospital Clinic de Barcelona — Barcelona, Spain
- Institut Catala D'oncologia — Barcelona, Spain
- Hospital Arnau de Vilanova — Lleida, Spain
- Hospital General Universitario Gregorio Marañón — Madrid, Spain
- IOB del Hospital Ruber Internacional — Madrid, Spain
- Hospital HM Universitario Sanchinarro — Madrid, Spain
- Hospital Clinico Universitario de Valencia — Valencia, Spain
- Hospital Universitario Miguel Servet — Zaragoza, Spain
- Fondazione IRCCS Istituto Nazionale dei Tumori — Milan, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.